KORU Medical Systems, Inc. Cash Flow Statement
KRMD|12 years of annual SEC 10-K data (FY2011-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 12 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Operating Cash Flow
-$319,718
FY2025
Free Cash Flow
-$2M
FY2025
Capital Expenditures
$1M
Cash used for long-term assets
Dividends Paid
N/A
FY2025
KORU Medical Systems, Inc. used $319,718 in operating cash flow and negative free cash flow of $2M in FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score NaN (distress zone, below 1.23 threshold)
- Currently unprofitable: Net income is negative
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2017 | FY2015 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$6.1M | -$13.7M | -$8.7M | -$4.6M | -$1.2M | $564.3K | $910.6K | $782.9K | $753.1K | $725.8K | $815.9K | $704.1K |
| Depreciation & Amortization | $888.5K | $870.4K | $587.1K | $463.1K | $418.6K | $340.2K | $309.3K | $271.6K | $283.9K | $191.0K | $104.0K | $65.8K |
| Operating Cash Flow | -$319.7K | -$4.9M | -$5.4M | -$4.3M | -$743.3K | $320.6K | $1.5M | $1.9M | $954.4K | $784.8K | $560.6K | $1.0M |
| Capital Expenditures | $1.3M | $782.9K | $2.8M | $346.2K | $920.6K | $201.2K | $297.0K | $121.8K | $591.4K | $563.6K | $236.2K | $200.5K |
| Free Cash Flow | -$1.6M | -$5.7M | -$8.2M | -$4.7M | -$1.7M | $119.4K | $1.2M | $1.8M | $363.0K | $221.2K | $324.4K | $827.9K |
| Share Buybacks | - | - | - | - | - | $2.8K | - | - | $24.3K | - | - | - |
| FCF Margin | -4.8% | -19.9% | -29.3% | -19.9% | -6.9% | 0.5% | 6.8% | 14.6% | 3.2% | 2.9% | 5.1% | 16.8% |